MB

Morry Blumenfeld

Director at Momentis Surgical

Israel

Overview 

Morry Blumenfeld is a Venture Partner at OurCrowd MedTech Investments, with a background in medical devices and healthcare. He has served in leadership roles at various companies, including Momentis Surgical™ and Nanox Imaging, and has made investments in notable startups like Aposense. Blumenfeld's career highlights include serving as Chairman of the Advisory Board at Nanox Imaging and as Director at Momentis Surgical™, demonstrating his expertise in guiding medical technology companies and making successful investment decisions in the healthcare sector.

Work Experience 

MS

Momentis Surgical™

  • Director

    2023 - Current

NI

Nanox Imaging

  • Chairman, Advisory Board

    2012

    Consult with the management of Nanox, provide appropriate members of the Advisory Board, and help develop appropriate relationships for the company.

AT

Alpha Tau Medical

  • Director

    2016

    Alpha particle brachytherapy company

OurCrowd

  • Venture Partner and Chairman, Medical Advisory Board

    2014

    My responsibilities include creating the MAB, and selecting appropriate companies for potential investments by OurCrowd.

Quescon Consultants

  • CEO

    2012

    Consulting for medical device companies

A

Aposense

  • Director

    2007

    My responsibilities include serving on the Board of Directors, and helping to establish an appropriate Scientific Advisory Board for the Company.

Meditech Advisors, LLC and Meditech Advisors Management, LLC

  • Chief Investment Officer

    2003

    Meditech Advisors Management, LLC is a partner in Ziegler Meditech Partners, LLC, the General Partner of the Ziegler Meditech Equity Partners, LP, a fund specializing in investments in medical device and healthcare related companies. Meditech Advisors Management is an affiliate of Meditech Advisors, LLC.

Momentis Surgical™, previously Memic

  • Board Observer

    2016 - 2023

i

illumigyn

  • Director and Chairman, Scientific Advisory Board

    2013 - 2022

InSightec

  • Director

    2014 - 2021

Education 

Investments 

Aposense

Series Unknown

Total funding: $22M

Articles About Morry

Relevant Websites